Eledon Pharmaceuticals Quote - ELDN

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

2.54

Bid

2.41

Offer

2.70

Volume

113,056

2.34 Day's Range 2.66

1.07 52 Week Range 3.349

Market Cap

97.807M

Previous Close

2.38

Open

2.34

Last Trade

2.66

Last Trade Time

Financial Volume

US$ 280,208

VWAP

2.4785

Average Volume (3m)

219,589

Shares Outstanding

38,506,614

Dividend Yield

PE Ratio

-2.43

Earnings Per Share (EPS)

-1.05

Revenue

Net Profit

-40.33M

Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and for... Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and for patients living with ALS. The company's lead compound in development is AT-1501 which is the next generation anti-CD40L antibody. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.eledon.com

Headquarters

Dover, Delaware, USA

Founded

1970

Eledon Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ELDN. The last closing price for Eledon Pharmaceuticals was US$2.38. Over the last year, Eledon Pharmaceuticals shares have traded in a share price range of US$ 1.07 to US$ 3.349.

Eledon Pharmaceuticals currently has 38,506,614 shares in issue. The market capitalisation of Eledon Pharmaceuticals is US$97.81 million. Eledon Pharmaceuticals has a price to earnings ratio (PE ratio) of -2.43.

Eledon Presents Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation

Data from 13 participants presented at the American Transplant Congress continue to support safety and tolerability profile of tegoprubart Overall mean eGFR of all reported time points after day...

Form ARS - Annual Report to Security Holders

Period †	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.13	-4.86891385768	2.67	2.83	2.34	290132	2.66932325	CS
4	0.04	1.6	2.5	3.2	2.3	176043	2.76045373	CS
12	0.64	33.6842105263	1.9	3.349	1.52	219589	2.47077886	CS
26	0.99	63.8709677419	1.55	3.349	1.5199	145221	2.28318627	CS
52	1.09	75.1724137931	1.45	3.349	1.07	109585	1.96800018	CS
156	-5.45	-68.2102628285	7.99	8.49	1.07	83491	2.92892102	CS
260	-13.26	-83.9240506329	15.8	22.91	1.07	80174	3.95513237	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
HYTOHyTerra Ltd	AUD 0.015 (114.29%)	1.88M
EELENRG Elements Ltd	AUD 0.003 (50.00%)	50k
AN1Anagenics Ltd	AUD 0.01 (42.86%)	712.83k
BMOBastion Minerals Limited	AUD 0.007 (40.00%)	6.32M
HTGHarvest Technology Group Limited	AUD 0.019 (35.71%)	1.17M
AS2OAskari Metals Ltd	AUD 0.001 (-66.67%)	583.46k
TKMOTrek Metals Limited	AUD 0.001 (-66.67%)	277.78k
CAIOACalidus Resources Limited	AUD 0.001 (-66.67%)	238.1k
CAQCAQ Holdings Limited	AUD 0.018 (-63.27%)	412.57k
CNJConico Ltd	AUD 0.001 (-50.00%)	90
MAYMelbana Energy Limited	AUD 0.034 (-43.33%)	50.42M
SYASayona Mining Limited	AUD 0.038 (8.57%)	34.51M
IMMImmutep Limited	AUD 0.3425 (-19.88%)	33.29M
YALYancoal Australia Ltd	AUD 6.41 (2.40%)	21.28M
AZYAntipa Minerals Ltd	AUD 0.01 (-4.76%)	20.74M